So far, serious side effects havent been common, but heres what an early phase 2 study has shown: Pancreatitis: Happened in about 0.4% of people in the study Gallbladder problems: Reported in about 1.1% of participants Heart rhythm changes: Seen more often with retatrutide, about 6% compared to 3% with placebo Liver enzyme changes: Around 1% of participants had increases, but overall liver health stayed stable These results suggest a low but real chance of serious issues such as pancreatitis, gallbladder problems, severe GI events, and allergic reactions
August 10, 2023
Regular monitoring and open communication with your medical team will help mitigate these risks
Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 70(1), 513
Before paying for a multi-month plan, confirm the cancellation and refund policy in writing
Insomnia is not considered a primary side effect of semaglutide